ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant
- 31 October 2004
- journal article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 23 (10), 1163-1169
- https://doi.org/10.1016/j.healun.2003.08.022
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A third‐generation matrix metalloproteinase (MMP) inhibitor (ONO‐4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP‐expressing tumor cells in nude miceInternational Journal of Cancer, 2002
- Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia–reperfusion injuryBritish Journal of Surgery, 2000
- Lipid Lowering by Diet Reduces Matrix Metalloproteinase Activity and Increases Collagen Content of Rabbit AtheromaCirculation, 1998
- Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteersBritish Journal of Clinical Pharmacology, 1998
- Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in RabbitsJournal of Medicinal Chemistry, 1997
- Activated forms of MMP2 and MMP9 in abdominal aortic aneurysmsJournal of Vascular Surgery, 1996
- Matrix Metalloproteinases and Cardiovascular DiseaseCirculation Research, 1995
- In situ localization and quantification of seventy-two – kilodalton type IV collagenase in aneurysmal, occlusive, and normal aortaJournal of Vascular Surgery, 1995
- Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumorsJournal of Neurosurgery, 1994
- IMMUNOCYTOCHEMICAL INVESTIGATIONS OF VESSEL ALLOGRAFT ARTERIOSCLEROSIS USING SMOOTH MUSCLE CELL- AND MACROPHAGE-SPECIFIC MONOCLONAL ANTIBODIESTransplantation, 1990